Evaluation of Serum Leptin Levels and Growth in Patients with β-Thalassaemia Major

Table 1

Serum leptin, ferritin, age, weight, height, BMI -score, BMI, and IGF-1 in -TM patients and controls according to sex.

Variables	Sex	β-TM patients	Controls	value
	M/F	27/23	41/34
Age (years)	Male	13.6 ± 3.4	13.7 ± 3.1	>0.05
	Female	12.3 ± 3.3	12.6 ± 3.0	>0.05
Height (cm)	Male	141.93 ± 15.54	156.99 ± 16.07	<0.001
	Female	132.11 ± 12.58	147.82 ± 14.45	<0.001
Weight (kg)	Male	34.81 ± 11.78	54.05 ± 19.55	<0.001
	Female	30.52 ± 8.94	44.62 ± 15.96	<0.001
BMI -score	Male	−1.22 ± 1.15	0.42 ± 1.38	<0.001
	Female	−0.68 ± 1.04	0.09 ± 1.11	<0.004
BMI (kg/m^2)	Male	16.79 ± 2.12	21.2 ± 4.65	<0.001
	Female	17.12 ± 2.62	19.85 ± 4.67	<0.014
S. leptin (ng/mL)	Male	1.71 ± 1.27	3.92 ± 1.22	<0.001
	Female	3.27 ± 1.97	5.95 ± 2.43	<0.001
S. ferritin (ng/mL)	Male	5285.5 ± 3220.2	114.14 ± 65.31	<0.001
	Female	5084.0 ± 3260.5	67.74 ± 30.54	<0.001

The significant sex differences (males versus females) for the above parameters within each group of -TM and controls were assessed as follows: , .